La société pharmaceutique européenne STADA conclut un partenariat exclusif portant sur le cannabis médical avec MediPharm Labs

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Une grande étape marquée dans l’industrie mondiale du cannabis alors que STADA, en partenariat avec MediPharm, ouvre la voie en tant que grande société pharmaceutique commercialisant des produits à base de cannabis médicalEn validant les bonnes pratiques de fabrication de MediPharm Labs pour ce qui est de produire du cannabis de qualité pharmaceutique, ce partenariat complété par les 125 années d’expérience de STADA et sa plateforme éprouvée de commercialisation et de vente répondra à la demande croissante du marché du cannabis médical, en commençant en Allemagne, un marché estimé à 1,5 milliard d’euros d’ici 2025Peter Goldschmidt, PDG de STADA, a déclaré : « Ce partenariat avec MediPharm démontre l’ambition de STADA d’être le partenaire incontournable en termes de médicaments génériques, de santé des...

Europäisches Pharmaunternehmen STADA schließt mit MediPharm Labs exklusive Partnerschaft für medizinisches Cannabis

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Meilenstein für weltweite Cannabisbranche – STADA beschreitet in Partnerschaft mit MediPharm neue Wege und vermarktet als großes Pharmaunternehmen medizinische CannabisprodukteDie Partnerschaft bestätigt die Produktion von Cannabis in pharmazeutischer GMP-Qualität durch MediPharm Labs. STADAs 125-jähriger Tradition und erfahrene Marketing- und Vertriebsplattform sollen helfen, die wachsende Nachfrage nach medizinischem Cannabis zu befriedigen, beginnend in Deutschland – ein Markt, dessen Wert bis 2025 Schätzungen zufolge 1,5 Milliarden Euro erreichen wird.STADA CEO Peter Goldschmidt: „Die Partnerschaft mit MediPharm zeigt, dass STADA sich zum Ziel gesetzt hat, der Partner schlechthin für Generika, Verbrauchergesundheits- und Spezialprodukte zu werden. Mit MediPharm arbeiten wir mit einem sehr starken Partner im Bereich medizinisches Cannabis...

La società farmaceutica europea STADA entra in una partnership esclusiva con MediPharm Labs per la cannabis medica

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Una pietra miliare dell’industria globale della cannabis come STADA, in collaborazione con MediPharm, si apre la strada per diventare una grande azienda farmaceutica nella commercializzazione di prodotti a base di cannabis medicaLa partnership convalida la produzione di cannabis di qualità farmaceutica certificata GMP di MediPharm Labs e, in combinazione con i 125 anni di esperienza e la piattaforma avanzata di marketing e vendita di STADA, soddisferà la crescente domanda nel mercato della cannabis medica a partire dalla Germania, un mercato che si stima raggiungerà 1,5 miliardi di euro entro il 2025Peter Goldschmidt, CEO di STADA: “Questa partnership con MediPharm dimostra l’ambizione di STADA di essere il partner di fiducia nell’ambito dei farmaci generici, dei prodotti da banco e dei prodotti specializzati. Con MediPharm avviamo una...

Европейская фармацевтическая компания STADA вступает в эксклюзивное партнерство по медицинскому каннабису с MediPharm Labs

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Важная веха для мировой индустрии каннабиса, поскольку STADA в партнерстве с MediPharm прокладывает путь в качестве крупной фармацевтической компании, коммерциализирующей медицинские продукты из каннабиса.Партнерство подтверждает соответствие GMP по производству каннабиса фармацевтического качества MediPharm Labs и, в сочетании со 125-летним опытом STADA и опытной платформой маркетинга и продаж, удовлетворит растущий спрос на медицинском рынке каннабиса, начиная с Германии – рынок которой оценивается в 1,5 миллиарда евро к 2025 году.Генеральный директор STADA Peter Goldschmidt: «Это партнерство с MediPharm демонстрирует стремление STADA стать постоянным партнером в области дженериков, потребительских товаров для здоровья и специализированных продуктов. С MediPharm мы сотрудничаем с очень сильным партнером в области медицинского...

La farmacéutica europea STADA establece una alianza exclusiva para la distribución de cannabis medicinal con MediPharm Labs

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Marcando un hito para la industria mundial del cannabis, STADA se ha asociado con MediPharm y abre el camino para formar una gran empresa farmacéutica de productos médicos de cannabisLa asociación respalda la producción de cannabis de calidad farmacéutica conforme a las buenas prácticas de fabricación de MediPharm Labs y, unida a la trayectoria de 125 años de STADA y la experiencia de su plataforma de comercialización y ventas, nace con el objetivo de satisfacer la creciente demanda del mercado de cannabis medicinal. Su andadura dará comienzo en Alemania, un mercado que según las estimaciones tendrá un volumen de 1500 millones de euros antes de 2025.El CEO de STADA, Peter Goldschmidt, ha señalado: «Esta asociación con MediPharm es una prueba de la aspiración de STADA por convertirse en un socio preferente en lo que respecta a los medicamentos...

Crown Castle Announces Second Quarter 2020 Earnings Conference Call Details

Written by Customer Service on October 8, 2020. Posted in Public Companies.

HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) — Crown Castle International Corp. (NYSE: CCI) (“Crown Castle”) plans to release its third quarter 2020 results on Wednesday, October 21, 2020, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Thursday, October 22, 2020, at 10:30 a.m. eastern time. The conference call may be accessed by dialing 800-458-4148 and asking for the Crown Castle call (access code 3114175) at least 30 minutes prior to the start time. The conference call may also be accessed live over the Internet at http://investor.crowncastle.com. Any supplemental materials for the call will be posted on the Crown Castle website at http://investor.crowncastle.com. A telephonic replay of the conference call will be available from 1:30 p.m. eastern time on Thursday,...

MONMOUTH REAL ESTATE WILL HOST FOURTH QUARTER AND FISCAL YEAREND 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL

Written by Customer Service on October 8, 2020. Posted in Public Companies.

HOLMDEL, NJ, Oct. 08, 2020 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE:MNR) will host its Fourth Quarter and Fiscal Yearend 2020 Financial Results Webcast and Conference Call on Tuesday, November 24, 2020, at 10:00 a.m. Eastern Time. Senior management will discuss the results, current market conditions and future outlook at that time.Monmouth Real Estate’s Fourth Quarter and Fiscal Yearend 2020 financial results will be released on Monday, November 23, 2020, after the close of trading on the New York Stock Exchange, and will be available on the Company’s website at www.mreic.reit in the Investor Relations section, under Filings and Reports.To participate in the Webcast select the 4Q and Fiscal Yearend 2020 Webcast and Earnings Call icon on the homepage of the Company’s website at www.mreic.reit, in the Highlights...

Insurance Acquisition Corp. Announces Change of Time for Special Meeting of Stockholders

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Special Meeting of Stockholders will be held at 7:00 A.M. Eastern Time On October 13, 2020PHILADELPHIA, PA, Oct. 08, 2020 (GLOBE NEWSWIRE) — Insurance Acquisition Corp. (the “Company”) (Nasdaq: INSU) today announced a change in the time of its Special Meeting of Stockholders to be held virtually on October 13, 2020 (the “Special Meeting”). Notice of the change in the time of the Special Meeting is being provided to the Company’s stockholders in additional proxy materials filed with the U.S. Securities and Exchange Commission. The Special Meeting is being held to approve, among other things, the Company’s proposed business combination with Shift Technologies, Inc.The time of the Special Meeting has been changed from 10:00 a.m. Eastern Time to 7:00 a.m. Eastern Time on October 13, 2020 and will be held in a virtual meeting format only.Meeting...

Newscope Capital (d/b/a Pharmather) Announces Listing on the Canadian Securities Exchange

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Discovering and developing psychedelic pharmaceuticals to treat disorders of the brain and nervous systemTORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) — Newscope Capital Corporation (d/b/a Pharmather) (“Pharmather” or the “Company”) (CSE: PHRM), a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that the Company’s common shares have been approved for listing on the Canadian Securities Exchange (the “CSE”) and the Company expects to begin trading on the CSE under the trading symbol “PHRM” as of market open on October 9, 2020.Fabio Chianelli, Pharmather’s Chief Executive Officer, said, “I am very excited for this milestone, and I would like to thank our team and advisors for their efforts. Special thanks to our shareholders for their...

Alpine Banks of Colorado Increases Common Shareholder Dividend

Written by Customer Service on October 8, 2020. Posted in Public Companies.

Glenwood Springs, Colo., Oct. 08, 2020 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) announced today that a quarterly cash dividend of $18.00 per Class A and Class B common share will be paid on October 26, 2020, to shareholders of record at the close of business on October 19, 2020. This dividend is an increase of $2.00 per share, or 12.5% from the previous quarter.About Alpine Banks of ColoradoAlpine Banks of Colorado, through its wholly owned subsidiary Alpine Bank, is an employee-owned organization with $4.7 billion in assets–founded in 1973 and headquartered in Glenwood Springs, Colorado. With 40 banking offices across Colorado, Alpine Bank employs more than 750 people and serves more than 150,000 customers with personal, business, wealth management*, mortgage and electronic banking services. Alpine Bank has...

Day: October 8, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice